表紙
市場調査レポート

米国の病院での血液凝固検査市場

2016 Future Horizons and Growth Strategies in the US Hospital Hemostasis Diagnostic Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

発行 Venture Planning Group 商品コード 258705
出版日 ページ情報 英文 411 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。

Local License: 同一事業所内

Back to Top
米国の病院での血液凝固検査市場 2016 Future Horizons and Growth Strategies in the US Hospital Hemostasis Diagnostic Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
出版日: ページ情報: 英文 411 Pages
担当者のコメント
このシリーズは、他にも調査対象国がございます。詳細はお問合せください。
概要

当レポートでは、米国の病院検査室での血液凝固検査関連市場について分析し、市場関係者が直面している諸問題や、検査の実施状況、検査技術の最新動向、今後5年間の試薬・検査機器の市場動向(市場規模・売上高・市場シェアなど)、今後の市場展開の戦略や障害、各企業のプロファイルといった情報を盛り込んで、概略以下の構成でお届けします。

世界の市場・技術の概要

  • 主な血液凝固検査(ルーチン検査・特別検査)
    • イントロダクション
    • APTT(活性化部分トロンボプラスチン時間)
    • α2抗プラズミン物質
    • 抗トロンビンIII
    • 出血時間
    • D-ダイマー
    • エタノール凝固テスト
    • ユーグロブリン溶解
    • 因子測定(全12種類)
    • フィブリン分解物
    • フィブリノゲン(線維素原)
    • ヘパリン
    • ヒルジン
    • 凝血能亢進および血栓症
    • リポたんぱく質A
    • プラスミン
    • プラスミノゲン
    • プラスミノゲン活性化因子阻害因子(PAI)
    • 血小板機能検査
    • 血小板凝集
    • プロテインC&S
    • プロトロンビンフラグメント1.2
    • プロトロンビン時間(PT)
    • レプチラーセ時間
    • トロンビン時間
    • t-PA(組織型プラスミノゲン活性化因子)
    • フォン・ヴィレブランド因子
  • 各種装置のレビュー(全44種)
  • 主要な体外診断技術と潜在的な用途
    • 発色基質
    • モノクローナル/ポリクローナル抗体
    • 免疫学的検定
    • マイクロコンピュータ
    • オートメーション
    • ロボット工学
    • DNAプローブ
    • 人工知能
    • ドライケミストリー
    • バイオセンサー

米国市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主なサプライヤー

主な製品開発機会

分散型検査製品の設計基準

代替的な市場参入戦略

  • 内部開発
  • 協働事業協定
  • 大学との契約
  • 分散検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の限界
  • 特許保護
  • 規制による抑制
  • 分散型検査市場の課題

競合企業評価

  • Abbott
  • American Diagnostica
  • Avocet Medical
  • Axis-Shield
  • Beckman Coulter
  • Becton Dickinson
  • Bio/Data Corporation
  • Biosite
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC
  • Nanogen
  • Roche
  • Siemens
  • Sienco
  • シスメックス
  • Thermo Fischer
  • Trinity Biotech
  • ZyCare

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPCO15256

This new report from VPGMarketResearch.com contains 411 pages, 28 tables, and presents a comprehensive analysis of the US hospital hemostasis diagnostic testing market, including: 

  • Major issues pertaining to the US hospital coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. 
  • Volume and sales forecasts for 40 coagulation procedures performed in US hospitals, including typical coagulation daily work loads. 
  • Review of current instrumentation technologies, and a feature comparison of leading analyzers. 
  • Reagent and instrument sales forecasts. 
  • Sales and market shares of leading reagent and instrument suppliers. 
  • Review of coagulation technologies and their potential market applications. 
  • Major opportunities for new coagulation instruments and consumables. 
  • Profiles of  major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 
  • Business opportunities and strategic recommendations for instrument and reagent suppliers. 

         Contains 411 pages and 28 tables

Table of Contents

Worldwide Market and Technology Overview

A. Major Routine and Special Coagulation Tests

  • 1. Introduction
  • 2. Activated Partial Thromboplastin Time (APTT)
  • 3. Alpha-2 Antiplasmin
  • 4. Antithrombin III
  • 5. Bleeding Time
  • 6. D-Dimer
  • 7. Ethanol Flocculation Test
  • 8. Euglobulin Lysis
  • 9. Factor Assays
    • a. Introduction
    • b. Factor II
    • c. Factor V/Factor V Leiden
    • d. Factor VII
    • e. Factor VIII
    • f. Factor IX
    • g. Factor IXa
    • h. Factor X (Stuart Factor)
    • i. Factor Xa
    • j. Factor XI
    • k. Factor XII
    • l. Factor XIII
  • 10. Fibrin Degradation Products
  • 11. Fibrinogen
  • 12. Heparin
  • 13. Hirudin
  • 14. Hypercoagulability and Thrombosis
  • 15. Lipoprotein a
  • 16. Plasmin
  • 17. Plasminogen
  • 18. Plasminogen Activator Inhibitor (PAI)
  • 19. Platelet Function Tests
  • 20. Platelet Aggregation
  • 21. Proteins C and S
  • 22. Prothrombin Fragment 1.2
  • 23. Prothrombin Time (PT)
  • 24. Reptilase Time
  • 25. Thrombin Time
  • 26. Tissue-Type Plasminogen Activator (t-PA)
  • 27. Von Willebrand's Factor

B. Instrumentation Review

  • Introduction
  • Benk Hemolab
  • Benk TRT Thrombotimer
  • Bio/Data MCA 310
  • Bio/Data MCA 210
  • Bio/Data PAP-4C D/4D/4C
  • Cardiovascular Diagnostics COAG
  • Diagnostica Stago STA Compact
  • Diagnostica Stago STA-R
  • Diagnostica Stago Star 4/8
  • Helena Laboratories Cascade 480
  • Helena Laboratories Cascade M
  • Helena Laboratories PACKS-4
  • Helena THOR
  • Instrumentation Laboratory ACL 100 and 1000 series
  • Instrumentation Laboratory ACL6000
  • Instrumentation Laboratory ACL7000
  • Instrumentation Laboratory ACL9000
  • Instrumentation Laboratory Electra 1000C
  • Instrumentation Laboratory Electra 1400C
  • Instrumentation Laboratory Electra 1600/C
  • Instrumentation Laboratory Electra 1800C
  • Instrumentation Laboratory Futura
  • ITC Hemochron 8000
  • Roche Diagnostics CoaguChek
  • Siemens BCS
  • Siemens BCT
  • Siemens BF II/Fibrintimer Series
  • Sysmex CA-50
  • Sysmex CA-500
  • Sysmex CA-1500
  • Sysmex CA-5000/CA-1000
  • Sysmex CA-6000
  • Sysmex CA-7000
  • Teco Coatron II/Jr./AccuStasis 5000
  • Trinity Biotech Amax CS190
  • Trinity Biotech Amax CS400
  • Trinity Biotech Coag-A-Mate Max
  • Trinity Biotech KC 40, 4A, 1A Series
  • Trinity Biotech MDA 180
  • Trinity Biotech Coag-A-Mate MTX
  • Trinity Biotech Coag-A-Mate RA4
  • Trinity Biotech Coag-A-Mate XC/Plus
  • Trinity Biotech Coag-A-Mate XM

C. Major in Vitro Diagnostic Technologies and Their Potential Applications

  • 1. Chromogenic Substrates
  • 2. Monoclonal and Polyclonal Antibodies
  • 3. Immunoassays
    • a. Applications
    • b. Technological Principle
    • c. Enzyme Immunoassays (EIA)
      • Overview
      • ELISA
      • EMIT
      • Dot Immunobinding Assays
      • Capillary Immunoassays
      • Enzyme Amplification
      • Electrochemical Immunoassay
    • d. Fluorescent Immunoassays
      • Fluorescence Polarization
      • Time-Resolved Pulse Fluorescence
      • Fluorescence Lifetime
    • e. Latex Agglutination
    • f. Immunoprecipitation
  • 4. Microcomputers
  • 5. Automation
  • 6. Robotics
  • 7. DNA Probes
    • a. Overview
    • b. Amplification Methods
      • PCR
      • Ligase Chain Reaction
      • Branched DNA
      • Q-Beta Replicase
      • NASBA
      • SDA
      • 3 SR
      • HPA
      • Two-Tiered System
      • LAT
  • 8. Artificial Intelligence
  • 9. Dry Chemistry
  • 10. Biosensors

USA

  • A. Executive Summary
  • B. Business Environment
    • 1. Health Care Expenditures
    • 2. Cost Consciousness
    • 3. Industry Consolidation
    • 4. Managed Care
    • 5. Hospitals
    • 6. Admissions
    • 7. Length of Stay
    • 8. Industry Diversification
    • 9. Physician Demographics
    • 10. Population Aging
      • a. Chronic Illnesses
      • b. Disease Incidence
      • c. Susceptibility to Iatrogenesis
      • d. Multiple Illness Cases
    • 11. Laboratory Regulations

C. Market Structure

  • 1. Centralized Testing
    • a. Hospitals
    • b. Commercial laboratories
  • 2. Decentralized Testing
    • a. Physician Offices/Group Practices
    • b. Point-of-Care Testing
    • c. Home/Self Testing
    • d. Other Decentralized Testing Locations

D. Market Size, Growth And Major Suppliers

Major Product Development Opportunities

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types Of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers And Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge And Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • American Diagnostica
  • Avocet Medical
  • Axis-Shield
  • Beckman Coulter
  • Becton Dickinson
  • Bio/Data Corporation
  • Biosite
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • ITC
  • Nanogen
  • Roche
  • Siemens
  • Sienco
  • Sysmex
  • Thermo Fischer
  • Trinity Biotech
  • ZyCare

List of Tables

  • Major Companies Developing or Marketing Activated Clotting Time Tests
  • Major Companies Developing or Marketing APTT Tests
  • Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
  • Major Companies Developing or Marketing Antithrombin III Tests
  • Major Companies Developing or Marketing Bleeding Time Tests
  • Major Companies Developing or Marketing D-dimer Tests
  • Major Companies Developing or Marketing Factor Assays
  • Major Companies Developing or Marketing Fibrin Degradation Product Tests
  • Major Companies Developing or Marketing Fibrinogen Tests
  • Major Companies Developing or Marketing Heparin Tests
  • Major Companies Developing or Marketing Plasmin Tests
  • Major Companies Developing or Marketing Plasminogen Tests
  • Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
  • Major Companies Developing or Marketing Platelet Aggregation Tests
  • Major Companies Developing or Marketing Protein C Tests
  • Major Companies Developing or Marketing Protein S Tests
  • Major Companies Developing or Marketing PT Tests
  • Major Companies Developing or Marketing Thrombin Time Tests
  • Major Companies Developing or Marketing TPA Tests
  • Major Companies Developing or Marketing Von Willebrand's Factor Tests
  • Executive Summary Table: U.S.A., Hospital Coagulation Diagnostics
  • Market By Product Category
  • U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size
  • U.S.A., Hospital Laboratories Average Daily Test Volume
  • U.S.A., Hospital Laboratories Coagulation Test Volume by Assay
  • U.S.A., Major Suppliers of Coagulation Reagents, Estimated Sales and Market Shares
  • U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Sales and Market Shares
  • U.S.A., Coagulation Diagnostics Market By Product Category
  • U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares
Back to Top